Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation

Cellular Microbiology

Volumn 13, Issue 7, 2011, Pages 978-991

  Pescher, Pascale ^a,c   Blisnick, Thierry ^b   Bastin, Philippe ^b   Späth, Gerald F ^a,c  

^a Laboratory of Parasite Virulence   (France)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIOXIDANT; CELL PROTEIN; PEROXIDASE; PROTEOME; TRYPAREDOXIN PEROXIDASE; UNCLASSIFIED DRUG;

AMASTIGOTE; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENETIC TRAIT; HAMSTER; HEPATOSPLENOMEGALY; IN VITRO STUDY; LEISHMANIA DONOVANI; LEISHMANIASIS; MASS SPECTROMETRY; MOUSE; NONHUMAN; PARASITE VIRULENCE; PHAGOLYSOSOME; PHENOTYPE; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; SPLENOMEGALY; SURVIVAL; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ANIMALS; CELLS, CULTURED; CRICETINAE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION; LEISHMANIA DONOVANI; MACROPHAGES, PERITONEAL; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; PROTEOME; PROTOZOAN PROTEINS; SPLEEN; VIRULENCE;

CRICETINAE; LEISHMANIA DONOVANI; PROTOZOA;

EID: 79959248739     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2011.01593.x     Document Type: Article

References (68)

1. Acestor, N., Masina, S., Ives, A., Walker, J., Saravia, N.G., and Fasel, N. (2006) Resistance to oxidative stress is associated with metastasis in mucocutaneous leishmaniasis. J Infect Dis 194: 1160-1167.
2. Alexander, J., Coombs, G.H., and Mottram, J.C. (1998) Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J Immunol 161: 6794-6801.
3. Antoine, J.C., Prina, E., Courret, N., and Lang, T. (2004) Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts. Adv Parasitol 58: 1-68.
4. Atyame Nten, C.M., Sommerer, N., Rofidal, V., Hirtz, C., Rossignol, M., Cuny, G., etal. (2010) Excreted/secreted proteins from trypanosome procyclic strains. J Biomed Biotechnol 2010: 212817.
5. Bacchi, C.J., Sufrin, J.R., Nathan, H.C., Spiess, A.J., Hannan, T., Garofalo, J., etal. (1991) 5′-Alkyl-substituted analogs of 5′-methylthioadenosine as trypanocides. Antimicrob Agents Chemother 35: 1315-1320.
6. Baptista, C.S., Vencio, R.Z., Abdala, S., Carranza, J.C., Westenberger, S.J., Silva, M.N., etal. (2006) Differential transcription profiles in Trypanosoma cruzi associated with clinical forms of Chagas disease: maxicircle NADH dehydrogenase subunit 7 gene truncation in asymptomatic patient isolates. Mol Biochem Parasitol 150: 236-248.
7. Barak, E., Amin-Spector, S., Gerliak, E., Goyard, S., Holland, N., and Zilberstein, D. (2005) Differentiation of Leishmania donovani in host-free system: analysis of signal perception and response. Mol Biochem Parasitol 141: 99-108.
8. Bern, C., and Chowdhury, R. (2006) The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control. Indian J Med Res 123: 275-288.
9. Castro, H., Sousa, C., Santos, M., Cordeiro-da-Silva, A., Flohe, L., and Tomas, A.M. (2002) Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum. Free Radic Biol Med 33: 1552-1562.
10. Charest, H., and Matlashewski, G. (1994) Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene. Mol Cell Biol 14: 2975-2984.
11. Clos, J., Klaholz, L., Kroemer, M., Krobitsch, S., and Lindquist, S. (2001) Heat shock protein 100 and the amastigote stage-specific A2 proteins of Leishmania donovani. Med Microbiol Immunol 190: 47-50.
12. Comini, M.A., Krauth-Siegel, R.L., and Flohe, L. (2007) Depletion of the thioredoxin homologue tryparedoxin impairs antioxidative defence in African trypanosomes. Biochem J 402: 43-49.
13. Cook, M., and Tyers, M. (2007) Size control goes global. Curr Opin Biotechnol 18: 341-350.
14. Croft, S.L., Seifert, K., and Duchene, M. (2003) Antiprotozoal activities of phospholipid analogues. Mol Biochem Parasitol 126: 165-172.
15. Croft, S.L., Seifert, K., and Yardley, V. (2006) Current scenario of drug development for leishmaniasis. Indian J Med Res 123: 399-410.
16. De Souza Leao, S., Lang, T., Prina, E., Hellio, R., and Antoine, J.C. (1995) Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J Cell Sci 108: 3219-3231.
17. Debrabant, A., Joshi, M.B., Pimenta, P.F., and Dwyer, D.M. (2004) Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics. Int J Parasitol 34: 205-217.
18. Denise, H., Poot, J., Jimenez, M., Ambit, A., Herrmann, D.C., Vermeulen, A.N., etal. (2006) Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5. BMC Mol Biol 7: 42.
19. Desjeux, P. (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305-318.
20. Doyle, P.S., Engel, J.C., Pimenta, P.F.P., da Silva, P.P., and Dwyer, D.M. (1991) Leishmania donovani: long-term culture of axenic amastigotes at 37°C. Exp Parasitol 73: 326-334.
21. Duncan, R., Alvarez, R., Jaffe, C.L., Wiese, M., Klutch, M., Shakarian, A., etal. (2001) Early response gene expression during differentiation of cultured Leishmania donovani. Parasitol Res 87: 897-906.
22. Ephros, M., Bitnun, A., Shaked, P., Waldman, E., and Zilberstein, D. (1999) Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob Agents Chemother 43: 278-282.
23. Gaur, U., Showalter, M., Hickerson, S., Dalvi, R., Turco, S.J., Wilson, M.E., and Beverley, S.M. (2009) Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts. Exp Parasitol 122: 182-191.
24. Gomez, M.A., Contreras, I., Halle, M., Tremblay, M.L., McMaster, R.W., and Olivier, M. (2009) Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases. Sci Signal 2: ra58.
25. Goyard, S., Segawa, H., Gordon, J., Showalter, M., Duncan, R., Turco, S.J., and Beverley, S.M. (2003) An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans. Mol Biochem Parasitol 130: 31-42.
26. Guerin, P.J., Olliaro, P., Sundar, S., Boelaert, M., Croft, S.L., Desjeux, P., etal. (2002) Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2: 494-501.
27. Halle, M., Gomez, M.A., Stuible, M., Shimizu, H., McMaster, W.R., Olivier, M., and Tremblay, M.L. (2009) The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. J Biol Chem 284: 6893-6908.
28. Hem, S., Gherardini, P.F., Osorio y Fortea, J., Hourdel, V., Morales, M.A., Watanabe, R., etal. (2010) Identification of Leishmania-specific protein phosphorylation sites by LC-MS/MS and comparative genomics analyses. Proteomics 10: 3868-3883. Sep 9. [Epub ahead of print].
29. Hofmann, B., Hecht, H.J., and Flohe, L. (2002) Peroxiredoxins. Biol Chem 383: 347-364.
30. Hoyer, C., Zander, D., Fleischer, S., Schilhabel, M., Kroener, M., Platzer, M., and Clos, J. (2004) A Leishmania donovani gene that confers accelerated recovery from stationary phase growth arrest. Int J Parasitol 34: 803-811.
31. Iyer, J.P., Kaprakkaden, A., Choudhary, M.L., and Shaha, C. (2008) Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence. Mol Microbiol 68: 372-391.
32. Jhingran, A., Chawla, B., Saxena, S., Barrett, M.P., and Madhubala, R. (2009) Paromomycin: uptake and resistance in Leishmania donovani. Mol Biochem Parasitol 164: 111-117.
33. Krobitsch, S., Brandau, S., Hoyer, C., Schmetz, C., Hubel, A., and Clos, J. (1998) Leishmania donovani heat shock protein 100. Characterization and function in amastigote stage differentiation. J Biol Chem 273: 6488-6494.
34. McCall, L.I., and Matlashewski, G. (2010) Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 is a stress response protein. Mol Microbiol 77: 518-530.
35. Matlashewski, G. (2001) Leishmania infection and virulence. Med Microbiol Immunol 190: 37-42.
36. Morales, M.A., Renaud, O., Faigle, W., Shorte, S.L., and Spath, G.F. (2007) Over-expression of Leishmania major MAP kinases reveals stage-specific induction of phosphotransferase activity. Int J Parasitol 37: 1187-1199.
37. Morales, M.A., Watanabe, R., Laurent, C., Lenormand, P., Rousselle, J.C., Namane, A., and Spath, G.F. (2008) Phosphoproteomic analysis of Leishmania donovani pro- and amastigote stages. Proteomics 8: 350-363.
38. Morales, M.A., Pescher, P., and Spath, G.F. (2010a) Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage. Eukaryot Cell 9: 22-30.
39. Morales, M.A., Watanabe, R., Dacher, M., Chafey, P., Osorio y Fortea, J., Scott, D.A., etal. (2010b) Phosphoproteome dynamics reveal heat-shock protein complexes specific to the Leishmania donovani infectious stage. Proc Natl Acad Sci USA 107: 8381-8386.
40. Mottram, J.C., Brooks, D.R., and Coombs, G.H. (1998) Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr Opin Microbiol 1: 455-460.
41. Mottram, J.C., Coombs, G.H., and Alexander, J. (2004) Cysteine peptidases as virulence factors of Leishmania. Curr Opin Microbiol 7: 375-381.
42. Piacenza, L., Peluffo, G., Alvarez, M.N., Kelly, J.M., Wilkinson, S.R., and Radi, R. (2008) Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite. Biochem J 410: 359-368.
43. Pineyro, M.D., Parodi-Talice, A., Arcari, T., and Robello, C. (2008) Peroxiredoxins from Trypanosoma cruzi: virulence factors and drug targets for treatment of Chagas disease? Gene 408: 45-50.
44. Romao, S., Castro, H., Sousa, C., Carvalho, S., and Tomas, A.M. (2009) The cytosolic tryparedoxin of Leishmania infantum is essential for parasite survival. Int J Parasitol 39: 703-711.
45. Rosenzweig, D., Smith, D., Myler, P.J., Olafson, R.W., and Zilberstein, D. (2008a) Post-translational modification of cellular proteins during Leishmania donovani differentiation. Proteomics 8: 1843-1850.
46. Rosenzweig, D., Smith, D., Opperdoes, F., Stern, S., Olafson, R.W., and Zilberstein, D. (2008b) Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J 22: 590-602.
47. Saar, Y., Ransford, A., Waldman, E., Mazareb, S., Amin-Spector, S., Plumblee, J., etal. (1998) Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani. Mol Biochem Parasitol 95: 9-20.
48. Sacks, D.L., Modi, G., Rowton, E., Spath, G., Epstein, L., Turco, S.J., and Beverley, S.M. (2000) The role of phosphoglycans in Leishmania-sand fly interactions. Proc Natl Acad Sci USA 97: 406-411.
49. Saravia, N.G., Escorcia, B., Osorio, Y., Valderrama, L., Brooks, D., Arteaga, L., etal. (2006) Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models. Vaccine 24: 4247-4259.
50. Saxena, A., Lahav, T., Holland, N., Aggarwal, G., Anupama, A., Huang, Y., etal. (2007) Analysis of the Leishmania donovani transcriptome reveals an ordered progression of transient and permanent changes in gene expression during differentiation. Mol Biochem Parasitol 152: 53-65. Epub 2006 Dec 2012.
51. Schluter, A., Wiesgigl, M., Hoyer, C., Fleischer, S., Klaholz, L., Schmetz, C., and Clos, J. (2000) Expression and subcellular localization of cpn60 protein family members in Leishmania donovani. Biochim Biophys Acta 1491: 65-74.
52. Seifert, K., Perez-Victoria, F.J., Stettler, M., Sanchez-Canete, M.P., Castanys, S., Gamarro, F., and Croft, S.L. (2007) Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. Int J Antimicrob Agents 30: 229-235.
53. Silverman, J.M., Chan, S.K., Robinson, D.P., Dwyer, D.M., Nandan, D., Foster, L.J., and Reiner, N.E. (2008) Proteomic analysis of the secretome of Leishmania donovani. Genome Biol 9: R35.
54. Silverman, J.M., Clos, J., de'Oliveira, C.C., Shirvani, O., Fang, Y., Wang, C., etal. (2010) An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci 123: 842-852.
55. Souza, A.E., Bates, P.A., Coombs, G.H., and Mottram, J.C. (1994) Null mutants for the lmcpa cysteine proteinase gene in Leishmania mexicana. Mol Biochem Parasitol 63: 213-220.
56. Spath, G.F., Epstein, L., Leader, B., Singer, S.M., Avila, H.A., Turco, S.J., and Beverley, S.M. (2000) Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc Natl Acad Sci USA 97: 9258-9263.
57. Spath, G.F., Lye, L.F., Segawa, H., Sacks, D.L., Turco, S.J., and Beverley, S.M. (2003a) Persistence without pathology in phosphoglycan-deficient Leishmania major. Science 301: 1241-1243.
58. Spath, G.F., Garraway, L.A., Turco, S.J., and Beverley, S.M. (2003b) The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc Natl Acad Sci USA 100: 9536-9541.
59. Strange, K., Denton, J., and Nehrke, K. (2006) Ste20-type kinases: evolutionarily conserved regulators of ion transport and cell. Physiology (Bethesda) 21: 61-68.
60. Turco, S.J., Spath, G.F., and Beverley, S.M. (2001) Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol 17: 223-226.
61. Walker, J., Acestor, N., Gongora, R., Quadroni, M., Segura, I., Fasel, N., and Saravia, N.G. (2006) Comparative protein profiling identifies elongation factor-1beta and tryparedoxin peroxidase as factors associated with metastasis in Leishmania guyanensis. Mol Biochem Parasitol 145: 254-264.
62. Wiesgigl, M., and Clos, J. (1999) Uniform distribution of transcription complexes over the entire Leishmania donovani clpB (hsp 100) gene locus. Protist 150: 369-373.
63. Wiesgigl, M., and Clos, J. (2001a) Heat Shock Protein 90 Homeostasis Controls Stage Differentiation in Leishmania donovani. Mol Biol Cell 12: 3307-3316.
64. Wiesgigl, M., and Clos, J. (2001b) The heat shock protein 90 of Leishmania donovani. Med Microbiol Immunol 190: 27-31.
65. Williams, R.A., Tetley, L., Mottram, J.C., and Coombs, G.H. (2006) Cysteine peptidases CPA and CPB are vital for autophagy and differentiation in Leishmania mexicana. Mol Microbiol 61: 655-674.
66. Wyllie, S., Vickers, T.J., and Fairlamb, A.H. (2008) Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials. Antimicrob Agents Chemother 52: 1359-1365.
67. Wyllie, S., Mandal, G., Singh, N., Sundar, S., Fairlamb, A.H., and Chatterjee, M. (2010) Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates. Mol Biochem Parasitol 173: 162-164.
68. Zilberstein, D., and Shapira, M. (1994) The role of pH and temperature in the development of Leishmania parasites. Annu Rev Microbiol 48: 449-470.